ORP1

ORP1 (PF3D7_1146600) is an oocyst capsule protein required for sporozoite egress during the mosquito stage of the Plasmodium life cycle, characterized in the P. berghei ortholog (PMID:27982038). It carries a histone-fold domain (HFD) that mediates heterodimer formation with ORP2, and this HFD is essential for ORP1 function: its loss blocks oocyst rupture (PMID:27982038). The X-ray crystal structure of the ORP1/ORP2 HFD heterodimer, solved at 3.1 Å, defines the dimerization interface, which is pharmacologically targetable by cyclic peptides that inhibit ORP1–ORP2 dimerization in vitro (PMID:41506730). The ORP1/ORP2 dimer further recruits a third subunit, ORP3, through the conserved NF-YA helix A1 of ORP3, assembling a trimeric NF-Y-like complex that is essential for oocyst capsule excystation and sporozoite egress (PMID:42045549). Beyond its assembly into this capsule-localized complex and its role in oocyst rupture, no additional molecular activity for ORP1 has been characterized in the available corpus.

1. 2016 High

   Establishing whether ORP1 has a defined role in the mosquito stage, this work showed its histone-fold domain drives heterodimerization with ORP2 and is required for oocyst rupture, defining ORP1 as an egress factor rather than an uncharacterized ORF.

   Evidence Genetic knockout, HFD mutational analysis, and in vitro heterodimer reconstitution in P. berghei

   PMID:27982038

   Open questions at the time

   • Does not resolve the atomic geometry of the ORP1/ORP2 interface
   • Mechanism by which the dimer triggers capsule rupture is unspecified
   • Whether additional subunits participate is not addressed
2. 2016 Medium

   To place ORP1 at the site of its function, imaging localized it to the oocyst capsule at the time of rupture, linking the biochemical activity to a defined subcellular structure.

   Evidence Protein localization imaging at the oocyst capsule in P. berghei

   PMID:27982038

   Open questions at the time

   • Localization method not detailed in the abstract
   • Does not establish how ORP1 is targeted to the capsule
3. 2026 High

   To define the interface at atomic resolution and test its druggability, the ORP1/ORP2 HFD heterodimer structure was solved at 3.1 Å and cyclic peptides were shown to inhibit dimerization, demonstrating the interface is a targetable node.

   Evidence X-ray crystallography, GAL4 yeast two-hybrid cyclic peptide screen, in vitro dimerization inhibition, and molecular docking in P. berghei

   PMID:41506730

   Open questions at the time

   • In vitro inhibition not yet shown to block oocyst rupture in vivo
   • Selectivity of the cyclic peptides against host complexes not addressed
4. 2026 High

   Extending the dimer to a higher-order assembly, ORP1/ORP2 were shown to recruit ORP3 via the NF-YA helix A1 to form a trimeric NF-Y-like complex essential for excystation, revealing the functional unit is a trimer.

   Evidence Yeast three-hybrid reconstitution, ORP3 knockout with oocyst rupture phenotyping, and ORP3 helix A1 deletion mutagenesis in P. berghei

   PMID:42045549

   Open questions at the time

   • Whether the trimer acts as a transcription factor or via a non-transcriptional role at the capsule is not established
   • Downstream effectors of rupture are unidentified
   • Stoichiometry and dynamics in vivo not resolved

• The biochemical mechanism by which the ORP1/ORP2/ORP3 trimeric complex executes oocyst capsule rupture, and whether the P. falciparum ortholog behaves identically to the P. berghei protein, remain open.
• No downstream target or enzymatic output of the complex identified
• Function characterized only in P. berghei ortholog, not in P. falciparum PF3D7_1146600 itself
• Regulation of complex assembly timing relative to rupture unknown